HEATHER BLACKBURN: Open Payments
NPI 1023684040 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 26 payments from 12 companies in 2025. Trend: 2023 $496 · 2024 $954 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| ABIOMED | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 2 | $36 |
| BridgeBio Pharma, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Amgen Inc. | 1 | $19 |
Products named: Kerendia, LEQVIO, FARXIGA, ONPATTRO, VYNDAQEL, Attruby, CAMZYOS, SHINGRIX.
Industry payments across NC — which companies pay providers there.
